Sun Pharma
Kumar Deep Das has a diverse work experience in the technology and cybersecurity field. Kumar Deep currently holds the position of Global Head - Technology Infrastructure & Cybersecurity at SUN PHARMA since June 2020. Prior to that, they were the Vice President - Technology at Essel Group from June 2007 to May 2020. Kumar Deep has also held positions such as Asst. Manager at WNS Global Services from June 2006 to May 2007, Team Leader at Colt Technology Services in April 2006, and Senior Executive / Team Lead at Wipro from October 2003 to April 2006.
Kumar Deep Das obtained a Master of Business Administration (MBA) in Information Technology and Project Management from NIMS in 2009. Prior to that, they completed a Bachelor's degree in Commerce from Assam (Central) University in 2003 and a 12th Board Examination in Commerce from Assam Higher Secondary Council in 2001. Kumar Deep also completed a 10th Board Examination from Holy Cross School in Assam in 1999. In addition to their formal education, Kumar Deep Das has obtained several certifications, including a Strategic Leadership Program from the Indian Institute of Management Ahmedabad in 2022, a Digital Transformation for Tech Leaders certification from LinkedIn in 2020, a Leading with Emotional Intelligence certification from the Project Management Institute, Mass Bay Chapter in 2020, and an IT Security Certification from LinkedIn in 2020. Kumar Deep also holds certifications in Software Engineering and Web Development from IBM in 2003 and Network Centered Computing from NIIT Limited in 2000.
Sun Pharma
21 followers
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 2,000 scientists and R&D investments of over 7-8% of annual revenues. See our community guideline: bit.ly/3DsQxdK